NASDAQ:EARS
Altamira Therapeutics Ltd.
- Stock
Last Close
0.91
30/08 20:00
Market Cap
2.89M
Beta: 1.40
Volume Today
37.01K
Avg: 1.89M
PE Ratio
−0.05
PFCF: −0.22
Preview
Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page
Dec '13 | Dec '14 | Dec '15 | Dec '16 | Dec '17 | Dec '18 | Dec '19 | Dec '20 | Dec '21 | Dec '22 | Dec '23 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
net income | -15.00M - | -18.19M 21.20% | -29.71M 63.35% | -30.66M 3.22% | -24.41M 20.39% | -11.50M 52.90% | -6.63M 42.31% | -8.20M 23.65% | -17.39M 112.07% | -26.53M 52.55% | -3.87M 85.41% | |
depreciation and amortization | 37.52K - | 73.98K 97.20% | 92.78K 25.40% | 97.60K 5.20% | 122.78K 25.80% | 72.71K 40.78% | 30.82K 57.61% | 20.04K 35.00% | 76.36K 281.10% | 118.89K 55.70% | 119.30K 0.35% | |
deferred income tax | 305.75K - | -4.09M 1,436.28% | -1.06M 74.16% | -131.06K 87.59% | -17.77K 86.44% | 162.18K 1,012.49% | -193.84K 219.52% | -21.28K 89.02% | 21.62K 201.58% | -10.33K 147.78% | -99.85K 866.67% | |
stock based compensation | 110.20K - | 270.75K 145.69% | 311.67K 15.12% | 290.78K 6.70% | 354.85K 22.03% | 27.73K 92.19% | 226.60K 717.17% | 368.79K 62.75% | 1.21M 227.09% | 342.80K 71.58% | 379.41K 10.68% | |
change in working capital | 471.22K - | 2.61M 454.39% | 1.67M 36.24% | 271.93K 83.68% | -468.19K 272.18% | -2.47M 428.22% | -1.22M 50.51% | 300.52K 124.55% | 511.11K 70.07% | 3.56M 596.47% | -4.24M 219.14% | |
accounts receivables | -18.93K - | 254.44K 1,444.45% | -340.12K 233.67% | -103.60K 69.54% | ||||||||
inventory | -839.22K - | 827.58K 198.61% | -319.82K 138.65% | |||||||||
accounts payables | -2.03M - | 632.47K 131.17% | -637.18K 200.74% | 340.12K - | 103.60K 69.54% | |||||||
other working capital | 3.69M - | -360.55K 109.76% | 168.98K 146.87% | -1.21M - | 46.09K 103.82% | 1.35M 2,830.02% | 2.73M 102.33% | -3.92M 243.52% | ||||
other non cash items | 36.20K - | -2.50K 106.90% | -36.39K 1,356.77% | 679.38K 1,966.95% | 142.04K 79.09% | 474.70K 234.20% | -601.08K 226.62% | 2.69M 547.30% | 1.90M 29.26% | 13.83M 627.33% | -3.80M 127.47% | |
net cash provided by operating activities | -14.04M - | -19.32M 37.54% | -28.73M 48.72% | -29.45M 2.53% | -24.28M 17.58% | -13.23M 45.49% | -8.39M 36.57% | -4.84M 42.29% | -13.67M 182.29% | -8.68M 36.49% | -11.51M 32.57% | |
investments in property plant and equipment | -108.94K - | -1.24M 1,036.90% | -79.92K 93.55% | -244.32K 205.71% | -152.97K 37.39% | -1.89M 1,136.27% | -3.02M 59.62% | -2.32M 23.30% | -3.33M 43.66% | -2.14M 35.57% | ||
acquisitions net | 1.43M - | |||||||||||
purchases of investments | ||||||||||||
sales maturities of investments | 10.04K - | |||||||||||
other investing activites | 74.04K - | 52.13K 29.58% | 36.56K 29.87% | 67.55K 84.76% | 53.57K 20.70% | 68.16K 27.24% | 17.88K 73.76% | 258 98.56% | -179.10K 69,520.16% | 969 100.54% | 505 47.88% | |
net cash used for investing activites | -34.90K - | -1.19M 3,299.32% | -43.36K 96.35% | -176.77K 307.70% | -99.40K 43.77% | -1.82M 1,733.98% | -3.00M 64.61% | -2.31M 22.85% | -3.51M 51.41% | -2.14M 38.89% | 1.44M 167.46% | |
debt repayment | -2.09M - | -9.27M 344.27% | -1.46M 84.22% | -68.70K - | -114.25K 66.30% | -1.45M 1,169.99% | ||||||
common stock issued | 24.12M - | 50.04M 107.45% | 21.07M 57.89% | 13.04M - | 17.45M 33.81% | 9.79M 43.87% | ||||||
common stock repurchased | ||||||||||||
dividends paid | ||||||||||||
other financing activites | 13.76M - | -428.69K 103.12% | -152.11K 64.52% | 11.44M 7,619.78% | -2.73M 123.87% | -2.44M 10.55% | -952.36K 61.01% | 16.96M 1,880.95% | 6.68M 60.60% | 9.95M 48.84% | -786.29K 107.91% | |
net cash used provided by financing activities | 37.88M - | 49.61M 30.96% | 20.92M 57.83% | 11.44M 45.32% | 8.22M 28.13% | 5.73M 30.27% | 7.38M 28.70% | 16.96M 129.89% | 6.61M 61.01% | 9.83M 48.66% | 10.62M 8.03% | |
effect of forex changes on cash | -495 - | 3.96M 800,449.70% | 1.15M 70.86% | 396.67K 65.64% | -1.32M 431.52% | -257.64K 80.41% | 7.74K 103.01% | 71.53K 823.62% | 289.39K 304.60% | 24.28K 91.61% | 46.59K 91.93% | |
net change in cash | 23.80M - | 33.07M 38.93% | -6.70M 120.25% | -17.80M 165.72% | -17.47M 1.83% | -9.58M 45.16% | -4.01M 58.16% | 9.87M 346.33% | -10.27M 204.06% | -968.80K 90.57% | 602.01K 162.14% | |
cash at beginning of period | 63.97K - | 23.87M 37,209.62% | 56.93M 138.56% | 50.24M 11.76% | 32.44M 35.42% | 14.97M 53.85% | 5.39M 63.98% | 1.38M 74.32% | 11.26M 713.08% | 984.19K 91.26% | 15.39K 98.44% | |
cash at end of period | 23.87M - | 56.93M 138.56% | 50.24M 11.76% | 32.44M 35.42% | 14.97M 53.85% | 5.39M 63.98% | 1.38M 74.32% | 11.26M 713.08% | 984.19K 91.26% | 15.39K 98.44% | 617.41K 3,910.45% | |
operating cash flow | -14.04M - | -19.32M 37.54% | -28.73M 48.72% | -29.45M 2.53% | -24.28M 17.58% | -13.23M 45.49% | -8.39M 36.57% | -4.84M 42.29% | -13.67M 182.29% | -8.68M 36.49% | -11.51M 32.57% | |
capital expenditure | -108.94K - | -1.24M 1,036.90% | -79.92K 93.55% | -244.32K 205.71% | -152.97K 37.39% | -1.89M 1,136.27% | -3.02M 59.62% | -2.32M 23.30% | -3.33M 43.66% | -2.14M 35.57% | ||
free cash flow | -14.15M - | -20.55M 45.24% | -28.81M 40.15% | -29.70M 3.09% | -24.43M 17.74% | -15.12M 38.09% | -11.41M 24.54% | -7.16M 37.27% | -17.00M 137.45% | -10.83M 36.31% | -11.51M 6.33% |
All numbers in USD (except ratios and percentages)